not posted for a year. back time. feeling we are about to rocket. Pfizer/ AZN uncertainty interesting. can see a bit more research money and attention coming our way (ICR/ CRT etc) pending the dust settling.
The quiet period won't last but always nice to discuss the possibilities.
50sBoy. Anything is possible with funding but if someone were to pay SARs share, they would want something in return.
And just noticed this. Not SAR specific but nice background on the oncology sector, ALL (which is one of the leukaemias Aurora FLT3 is going after), immunotherapy (not measles unfortunately) but some very nice, big numbers.
We all know its high risk, but this shows what some of the rewards could be
Hopkirk Evening good to see a chatty bb - my point entirely if things are looking positive then Sar should be saying we have the "cake" who wants a bite because we are adding a layer, unless TM has locked into a "rolling contract", which will be somewhat disappointing if the product is improving and the finance from outside isn't.
Anyway, as you said lots of possibilities.......and so far science has been good!!
I confess i know very little as to raising funds in these situations, but i would think this was all through well through before arriving where we are today. Hopkirk, can't remember if you corrected me on this before, but isn't it possible that a backer may pay what ever is needed on behalf of Sar, or is that not possible........my thoughts only
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.